Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH)

Hepato-Gastroenterology

Volumn 53, Issue 71, 2006, Pages 678-681

  Sasaki, Nozomi ^a   Ueno, Takato ^b,d   Morita, Yasuyo ^c   Nagata, Eisuke ^c   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c Nagata Hospital   (Japan)

^d NONE   (Japan)

Author keywords

Diagnosis; Hepatic fibrosis; Hepatic fibrosis marker; Necroinflammation; Nonalcoholic steatohepatitis (NASH)

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 4; FAT DROPLET; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HYALURONIC ACID; IRON; LEPTIN; PROCOLLAGEN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CHEMISTRY; BODY MASS; CLINICAL ARTICLE; DIET RESTRICTION; DRUG ABUSE; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

BIOLOGICAL MARKERS; COLLAGEN TYPE IV; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; HYALURONIC ACID; LEPTIN; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; ROC CURVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750576507     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Adler M, Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67:811-816.
2. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434-438.
3. Dixon JB, Bhathal PS, O'Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121:91-100.
4. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114:311-318.
5. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashita S, Kitamura T, Sato N: Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122:1399-1410.
6. Saxena NK, Ikeda K, Rockey DC, Frieman SL, Anania FA: Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35:762-771.
7. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J: Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002; 36:403-409.
8. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
9. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123:745-750.
10. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37:1202-1219.
11. Sanyal AJ: Nonalcoholic steatohepatitis. Clin Perspectives Gastroenterol 2000; 3:129-139.
12. Murawaki Y, Ikuta Y, Koda M, Kawasaki H: Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994; 20:780-787.
13. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, Minetoma T, Kimura Y, Ohira H, Sata M, Yoshida H, Tanikawa K: Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993; 105:475-481.